---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-250614"
form_type: "8-K"
ticker: "RANI"
cik: "0001856725"
company_name: "Rani Therapeutics Holdings, Inc."
filed_at: "2025-10-27T23:59:59+00:00"
generated_at: "2026-05-17T02:13:39.990637+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Rani Therapeutics closes private placement of 42.6M shares and warrants; board changes

## Summary
- Closed private placement of 42,633,337 shares of Class A common stock, warrants to purchase 125,000,004 shares, and pre-funded warrants for 82,366,667 shares.
- Post-closing shares outstanding: 97,541,221.
- Directors Andrew Farquharson and Maulik Nanavaty resigned effective closing; no disagreement cited.
- Abraham Bassan (Samsara BioCapital) and Vasudev Bailey (Anomaly Ventures) appointed as directors.
- Samsara and Anomaly each have board designation rights while holding at least 25% of securities issued.

## SEC filing metadata
- accession: 0001193125-25-250614
- form_type: 8-K
- ticker: RANI
- cik: 0001856725
- company_name: Rani Therapeutics Holdings, Inc.
- filed_at: 2025-10-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1856725/000119312525250614/0001193125-25-250614-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1856725/000119312525250614/d935516d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-250614
- JSON: https://secwatch.observer/filing/0001193125-25-250614.json
- Plain text: https://secwatch.observer/filing/0001193125-25-250614.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.